Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Clinical trial Stories

2014-03-11 08:29:47

SAN DIEGO, March 11, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) announced today that the United States Adopted Names (USAN) Council has selected "vepoloxamer" as the unique non-proprietary (generic) name for the active pharmaceutical ingredient (API) in MST-188, the Company's lead product candidate. Mast sought a unique name for its API to clearly identify it as different from non-purified poloxamers. In support of its application, the Company argued that drug...

2014-03-10 08:20:54

Reusable and Single-use Shippers Ensure Temperature Protection for Clinical Trials Shipments ARLINGTON HEIGHTS, Ill., March 10, 2014 /PRNewswire/ -- Sonoco ThermoSafe, a unit of Sonoco (NYSE:SON) and a leading global provider of temperature assurance packaging, has launched the Via Series of pre-qualified temperature controlled shippers. The Via Series is Sonoco ThermoSafe's most rigorously tested solution for maintaining pharmaceuticals, biologics, vaccines and other high-value...

2014-03-07 23:21:02

One of the nation’s largest clinical research programs has chosen to use SIGNiX’s electronic signature service to speed up the consent process for clinical trials. Chattanooga, Tenn. (PRWEB) March 07, 2014 SIGNiX, the most trusted name in digital signatures, today announced that one of the nation’s largest clinical research institutes selected SIGNiX to accelerate and simplify its consent process. SIGNiX’s technology will enable patients and clinical investigators to sign consent...

2014-03-07 16:23:04

REDWOOD CITY, Calif., March 7, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and CEO will present a Company update at the following conference: 26(th) Annual Roth ConferenceDate: Tuesday, March 11, 2014Location: The Ritz Carlton, Laguna Niguel, CAPresentation...

2014-03-07 08:25:40

BETHESDA, Md., March 7, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today, in response to shareholder inquiries, that the Data Safety Monitoring Board (DSMB) has made an unblinded review of the safety data for the Company's ongoing international Phase III GBM Trial, and has recommended that the trial continue as planned....

2014-03-06 23:25:40

Xtalks presents a new and informative webinar that will focus on crucial techniques to ensure the success of your study. The broadcast takes place on Wednesday, March 26, 2014 10am EDT (2pm GMT). Toronto, Canada (PRWEB) March 06, 2014 It’s no secret that slow enrollment is one of the major factors that leads to delays in the completion of clinical trials. And while enrollment is already challenging, the increase in clinical trial complexity, number of study procedures, and increasingly...

2014-03-06 16:27:38

Clintrax to Use Acorn Applications' "TrialCTA" Cloud-Based Tracking Solution for Transparent and Accelerated Clinical Trial Agreement Negotiations RALEIGH, N.C., March 6, 2014 /PRNewswire/ -- Acorn Applications, LLC, a developer of cloud-based analytic clinical research solutions, announced today that Clintrax Global, a clinical trial contract negotiation company, has selected TrialCTA as its new global contract management software solution. TrialCTA, Acorn Applications' lead...

2014-03-06 16:26:58

LONDON and WILMINGTON, N.C., March 6, 2014 /PRNewswire/ --Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Chiltern has been recognized with a CRO Leadership Award in all five categories: Quality, Reliability, Productivity, Innovation and Regulatory. The awards are given by Life Science Leader publication based on the data-driven research of Nice Insight. Chiltern is the only organization to be recognized in all five categories...

2014-03-06 16:26:42

RYE, N.Y., March 6, 2014 /PRNewswire/ -- Joan Fallon, founder and CEO of Curemark LLC, a research-driven biotechnology company focused on neurological disorders, will be a featured speaker at the SXSW Interactive Festival to be held March 7-11 in Austin, Texas. SXSW Interactive, part of South by Southwest,(TM) brings together the brightest minds in cutting-edge technologies, digital creativity and startup innovation. Dr. Fallon will be joined by Amy Millman, President of...

2014-03-06 12:27:23

iMedNet(TM) EDC's Exceptional Functionality, Flexibility and Cost Effectiveness Identified as Key Factors in Oncotherapeutics' Selection of MedNet Solutions as their Technology Partner MINNETONKA, Minn., March 6, 2014 /PRNewswire/ -- MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that Oncotherapeutics, a full service CRO with a unique focus on therapeutic oncology, is the most recent organization to join...